99 results
S-3ASR
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
of determining the voting
stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances … for the future issuance as of March 31, 2024 under our 2019 Employee Stock Purchase Plan; and
64,257 shares of common stock issuable upon the exercise
S-3ASR
EX-4.2
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
of legal counsel, who may be an employee of or counsel for the Company, that is delivered to the Trustee in accordance with the terms hereof. Each
S-3ASR
EX-4.3
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
to customary exceptions of legal counsel, who may be an employee of or counsel for the Company, that is delivered to the Trustee in accordance with the terms
PRE 14A
6xc 33qk4h
16 Apr 24
Preliminary proxy
4:30pm
8-K
EX-1.1
b8ttzpojxz02mtz
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
424B5
1x4fa4risrkk 5d
6 Mar 24
Prospectus supplement for primary offering
5:16pm
424B5
yqk9xqr 8sh7
4 Mar 24
Prospectus supplement for primary offering
5:21pm
S-8
EX-5.1
y6umbr3opoajk4wiam
29 Feb 24
Registration of securities for employees
4:42pm
S-8
llc2mdq fusz3zdn5jd
29 Feb 24
Registration of securities for employees
4:42pm
S-8
qg1din06j3394cmy kb
29 Feb 24
Registration of securities for employees
4:42pm
8-K
EX-1.1
elmwo9pr894s0g0r4n3
17 May 23
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
5:01pm
424B5
rjwjjz7jpjv tnaec
17 May 23
Prospectus supplement for primary offering
4:45pm